Burney Co. increased its stake in Autodesk, Inc. (NASDAQ:ADSK) by 8.2% in Q4, raising its holdings to 76,574 shares valued at $22.667 million, making it their 25th largest position. The software company recently beat earnings expectations with an EPS of $2.85 on $1.96 billion in revenue and provided optimistic FY2027 guidance. Despite recent analyst downgrades and price target trims, Autodesk maintains a "Moderate Buy" consensus rating with an average target price of $339.67.

Clear Creek Financial Management LLC, an institutional investor, has purchased 3,162 shares of The Sherwin-Williams Company (NYSE: SHW) in the fourth quarter of 2025, valuing the new stake at approximately $1,025,000. This move signifies ongoing investor interest in the specialty chemicals company and reflects the firm's perceived growth potential in Sherwin-Williams' business. Other investors, such as Brighton Jones LLC and Empowered Funds LLC, have also recently adjusted their holdings in the company.

Beacon Harbor Wealth Advisors Inc. acquired 11,184 new shares of UnitedHealth Group (NYSE: UNH) in Q4 2025, an investment valued at approximately $3.69 million. This move highlights continued institutional interest in the healthcare sector, particularly in large, diversified companies like UnitedHealth Group, which are seen as stable investments. The firm's SEC filing indicates a strategic placement in the healthcare giant.

Beacon Harbor Wealth Advisors Inc. has significantly increased its holdings in Procter & Gamble (NYSE:PG) by purchasing 20,668 shares, valued at approximately $2.96 million, during the fourth quarter of 2025. This move signals the firm's strong confidence in the consumer goods giant's resilience against economic challenges and its continued growth potential. The investment highlights P&G's status as a bellwether stock whose ownership changes offer insights into broader investment trends within the consumer staples sector.

JPMorgan Chase & Co. significantly reduced its stake in Tetra Technologies (NYSE:TTI) by 66.7% in Q3, selling 260,041 shares and now owning 129,565 shares valued at $745,000. Despite missing EPS expectations, Tetra Technologies exceeded revenue forecasts in its latest quarter and maintains a "Moderate Buy" consensus rating from analysts with an average target price of $10.25. Institutional investors and hedge funds hold a substantial 70.19% of the company's stock, with some analysts recently raising price targets to $11.50–$13.00.

comScore, Inc. (NASDAQ:SCOR) experienced a significant 155.4% increase in short interest in March, reaching 16,436 shares, which represents about 0.1% of the shares shorted and a short-interest ratio of 0.7 days. Hedge funds collectively own 42.15% of the stock, with Cerberus Capital Management dramatically boosting its stake by 2,997.5%. Analysts have a consensus "Hold" rating on the stock, which traded around $7.43 with a market capitalization of $111.6 million.

Short interest in SPDR S&P Kensho Intelligent Structures ETF (SIMS) significantly dropped by 50.5% in March, totaling 381 shares as of March 31st. This represents a short-interest ratio of 0.6 days based on its average daily volume, with approximately 0.2% of the company's stock currently short sold. Additionally, Susquehanna International Group LLP recently acquired a new position of 5,169 shares, valued at approximately $219,000, in the ETF.

The article highlights the difficulty of finding high-yielding U.S. stock funds and points to global and emerging market dividend ETFs as a solution. It notes that a handful of these funds offer yields of 5% or more. The Global X SuperDividend ETF is mentioned as an example, targeting high-yielding companies like Petrobras.

Wall Street Zen downgraded Science Applications International (SAIC) from a "buy" to a "hold" rating, aligning with a consensus "Hold" rating and an average price target of $112.44 among analysts. Despite beating EPS estimates with $2.62, the company's revenue of $1.75 billion slightly missed expectations and marked a 4.8% year-over-year decline. SAIC shares opened lower at $91.72, trading closer to its 12-month low, with a market capitalization of approximately $4.0 billion.

Stereotaxis, Inc. has begun its participation at EHRA2026 in Paris by promoting its GenesisX platform and inviting attendees to its booth. The company linked the conference's opening with the Paris Marathon to energize visitors and showcase its latest advancements in medical technology. This event follows previous announcements of new robotic electrophysiology innovations and the recent launch of a remote TeleRobotic Test Drive, emphasizing Stereotaxis's commitment to expanding access to advanced medical systems.